🧬

Dirty Med - Understanding Arachidonic Acid Pathways

May 6, 2025

Arachidonic Acid Pathway Lecture Notes

Overview

  • Arachidonic Acid (AA): Precursor of bioactive lipid metabolites known as eicosanoids.
  • Eicosanoids: Include prostaglandins, leukotrienes, and epoxyeicosatrienoic acids.
    • Pro-inflammatory, triggering oxidative stress and stimulating immune response.
  • Pathway Intervention: Can be targeted to treat/manage inflammation.

Arachidonic Acid Pathway

  1. Release: Arachidonic acid is released by phospholipase A2 from the membrane.
  2. Pathway Options:
    • Reincorporation: Back into the phospholipid membrane.
    • Enzymatic Conversion: Into downstream bioactive metabolites via two pathways:
      • Lipoxygenase Pathway (LOX) – Left
      • Cyclooxygenase Pathway (COX) – Right

Lipoxygenase Pathway (LOX)

  • Enzyme: 5-lipoxygenase converts AA into 5-HPETE.
  • Conversion:
    • 5-HPETE to Leukotriene A4 (LTA4)
    • LTA4 can form:
      • Leukotriene C4, D4, E4: Increase bronchial tone.
      • Leukotriene B4: Involved in neutrophil chemotaxis.

Cyclooxygenase Pathway (COX)

  • Enzymes: COX-1 and COX-2 convert AA into PGG2, then PGH2.
  • PGH2 Conversion:
    • To Prostacyclin (PGI2)
    • To Prostaglandins (PGE1, PGE2, PGF2)
    • To Thromboxanes (TXA2, TXB2)

Functions of Bioactive Products

  • Leukotriene B4: Neutrophil chemotaxis (mnemonic: LTB4 buses neutrophils).
  • Leukotriene C4, D4, E4: Increase bronchial tone (mnemonic: CDE bronchial tone).
  • Prostacyclin (PGI2): Decreases platelet aggregation, vasodilator.
  • PGE1: Vasodilator.
  • PGE2, PGF2: Increase uterine tone (mnemonic: EF2 uterine tone 2).
  • Thromboxane A2 (TXA2): Increases platelet aggregation, vasoconstrictor.

Medications Affecting the Pathway

  • Glucocorticoids: Inhibit phospholipase A2 (upstream action).
  • NSAIDs: Inhibit COX-1.
  • Celecoxib: Selectively inhibits COX-2 (fewer GI side effects).
  • Epoprostenol, Carboprost, Dinoprostone, Alprostadil: Inhibit prostaglandins/prostacyclin (mnemonic: 'Prost' in name).
  • Montelukast, Zafirlukast: Inhibit leukotrienes (mnemonic: Contains 'Luk').
  • Zileuton: Inhibits 5-lipoxygenase (mnemonic: A to Z, inhibits LTA4).

Key Takeaways

  • Important to understand pathways and functions of bioactive products.
  • Medications and their inhibition effects are crucial for understanding inflammatory responses.
  • If memorizing everything is difficult, remember that Leukotriene B4 is key for neutrophil chemotaxis.